Resultados de procura - Robert Karanja, PhD

Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in thr... por Marco Schäferhoff, PhD, Armand Zimmerman, MS, Mohamed M Diab, MD, Wenhui Mao, PhD, Vipul Chowdhary, MD, Davinder Gill, PhD, Robert Karanja, PhD, Mziwandile Madikizela, PhD, Osondu Ogbuoji, ScD, Gavin Yamey, ProfMD

Connect to this object online.